Leveraging Real-World Data for Precision Obesity Treatment
Today's episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.
Three Considerations to Expand Physicians’ Bandwidth and Improve Real-World Safety Reporting
The ever-expanding field of pharmacovigilance highlights the importance of identifying and tackling problems with real-world safety reporting. Despite this [...]
Hard to Define, Harder to Find Patients: Using AI & Real-World Data to Understand Treatment Resistant Depression
Mental health conditions can take a staggering toll on an individual physically, socially and financially. Many patients languish with [...]
Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
The healthcare industry -- from providers and health systems to payers -- is increasingly adopting value-based care practices, which [...]
Podcast Q&A: Designing Causal Inference Studies Using Real-World Data
This podcast segment features the Q&A from HealthCore's December 7, 2022 webinar and features an expert panel including Michael [...]
Using Real-World Data for Patients with Multiple Sclerosis: A New Machine Learning Model for the Expanded Disability Status Scale (EDSS)
Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds [...]
Real-World Data for Mental Health – Understanding Outcomes and Unlocking Pathways to More Precise Treatments
OM1 was founded by a team dedicated to the belief that participating in value-based healthcare requires a much more complete [...]
Podcast Q&A: FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation
This podcast segment features the Q&A from IQVIA's May 25, 2022 webinar hosted IQVIA experts Raina Olexa, Senior Principal Scientist [...]
Foundation of Sand
The last decade has seen an explosion of interest in and production of real world evidence (RWE). But I’m afraid there is a day of reckoning approaching.
Delivering Real World Data-Driven Insights: An Executive Interview with Wendy Shusko and Jason Drenning
Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason [...]
Supplier Spotlight: Veradigm
Supplier Spotlight® highlights the unique skill sets and service offerings of our vast supplier network. Below is an interview with Veradigm, [...]
Revealing the Unknown: How the COVID Active Research Experience (CARE) Registry is Enhancing Community Health
Since COVID-19 first emerged as a global pandemic, the pharmaceutical industry has risen to meet the virus' related challenges from a prevention as well as a treatment perspective.
Optimizing Real-World Evidence in Medical Device Development
The use of real-world data to generate RWE for medical devices by industry has become more prominent in recent years, and more attractive to a variety of stakeholders. It is used frequently to understand the use of the device in the larger clinical setting, but more recently it is also being used for regulatory decision making.
